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Severe Jaundice in Two Children with Kawasaki Disease:  
A Possible Association with Gilbert Syndrome
Kawasaki disease is a systemic vasculitis, mainly encountered in children. It may affect any 
organ. Acute cholestasis and severe obstructive jaundice is an atypical manifestation of the 
disease. We herein present two children with Kawasaki disease and severe direct 
hypebilibirunemia who also were homozygous and heterozygous respectively for the (TA)7  
promoter polymorphism of Gilbert syndrome. Intravenous immunoglobulin was 
administered to both patients at the acute phase of the disease and the fever remitted 
within 24 hr following the immunoglobulin administration. Furthermore oral aspirin at a 
dose of 80-100 mg/kg/24 hr was also given. The first child did not develop any coronary 
ectasia or aneurysm, whereas dilation of the right coronary artery was identified in the 
second child, one month after the disease onset. We discuss the possible contribution of 
Gilbert syndrome to the development of jaundice in our patients. 
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CASE REPORT
Pediatrics
INTRODUCTION
Kawasaki disease (KD) was first described in 1974 (1). Since then, 
a series of children diagnosed on the basis of certain clinical fea-
tures, have been reported and the disease has become the lead-
ing cause of acquired heart disease in children (2). Apart from 
the specific diagnostic criteria, there are several other early or 
late features of the disease (2, 3). Jaundice is a rather uncommon 
clinical finding, attributed mainly to direct hyperbilirubinemia 
due to liver dysfunction or cholestasis (4). Elevated bilirubin and 
increased CRP, LDH, γGT were associated with unresponsive-
ness to treatment with intravenous immunoglobulin (IVIG) (5). 
  We, herein, report two children with KD and severe direct hy-
perbilirubinemia who were either homozygous or heterozygous 
for the (TA)7 promoter polymorphism of Gilbert syndrome. This 
syndrome is a well known cause of indirect hyperbilirubinemia 
under certain circumstances (6). We discuss the possible con-
tribution of Gilbert syndrome to the development of jaundice 
in our patients. 
CASE DESCRIPTION
Case 1 
A 7-yr-old previously healthy boy was admitted to the hospital, 
in 2008, with abdominal pain, fever and rash. Physical examina-
tion revealed generalized rash, small palpable axillary lymph 
nodes and marginally palpable liver. Later, he developed jaun-
dice due to direct hypebilirubinemia accompanied with elevated 
aminotransferases. Abdonimal ultrasound and MRCP were per-
formed which were normal. The patient was initially given peni-
cilline which was changed to cefotaxime upon clinical suspicion 
of infection. The 3rd day of the disease he developed oedema of 
the hands and feet, conjunctivitis and cheleitis. The 5th day he 
was still febrile and IVIG at a dose of 2 g/kg plus aspirin at a dose 
of 80 mg/kg/24 hr were administered with the presumptive diag-
nosis of KD. Since then, the child remained afebrile, icterus grad-
ually remitted and transaminases returned to the normal range. 
A cardiologic evaluation with triplex ultrasound examination 
was performed on the 5th and the 10th day of the disease as well 
as six weeks later without revealing any ectasia or aneurysm for-
mation of the coronary arteries. Desquamation of fingers and 
toes developed on the 10th day. 
  On admission, the laboratory investigation showed white 
blood cells 11,920/μL with a shift to the left (neutrophils 89%, 
lymphocytes 4% and monocytes 7%), Hb 13.7 g/dL, Ht 40.2%, 
platelets 264,000/μL, CRP 80 mg/L. It is of note that hemoglobu-
lin gradually decreased to 8.2 g/dL and on the 10th day of the 
disease it returned to 9.6 g/dL. The blood cultures were sterile 
and PCR for pneumococcus, haemophilus, staphylococcus, me-
ningococcus, listeria and pseudomonas were negative. A strept Karpathios T, et al.  •  Kawasaki and Gilbert Syndrome
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test was also negative and pharyngeal culture revealed normal 
flora. 
  When jaundice was developed, bilirubin was as high as 7.45 
mg/dL with a direct component 4.86 mg/dL. It gradually de-
creased and on the 10th day of the disease it was 1.35 mg/dL, 
with a direct component of 0.74 mg/dL. SGOT was 84 U/L and 
SGPT 138 U/L on the 2nd day of the disease and gradually re-
turned to the normal range. PT and aPTT were within normal 
range, whereas γGT and alkaline phospatase were elevated (134 
U/L, 316 U/L respectively). As jaundice has been considered an 
atypical presentation of KD, serological analysis for several hep-
atotropic viruses as well as for ricketsia and leptospira was per-
formed. It revealed only antiHBs which were positive due to pre-
vious immunization. Because of the severity of jaundice the child 
was examined genotypically for Gilbert syndrome and Wilson’s 
disease. DNA analysis for Gilbert syndrome revealed homozy-
gosity for the (TA)7 promoter polymorphism.
Case 2 
A 3.5-yr-old girl was admitted to the hospital, in 2003, with high 
spiking fever of 4 days duration and generalized rash. She also 
developed jaundice and conjunctivitis 24 hr prior to admission. 
On clinical examination, she was in compromised general con-
dition, with erythema and swelling involving the upper and lower 
extremities, cheleitis, erythema of the genitals and hepatospleno-
megaly. At the clinical suspicion of a bacterial infection, cefotax-
ime and vancomycin were administered . 
  On admission, the laboratory investigation revealed leukocy-
tosis (white blood cells 31,400/μL, neutrophils 85% lymphocytes 
4%, monocytes 11%). Hb was 11 g/dL, Ht 32,4%, platelet count 
346,000/μL, CRP 247 mg/L and bilirubin 15.1 mg/dL with direct 
component of 12.5 mg/dL. The third day of hospitalization, Hb 
decreased to 7.4 g/dL and it returned gradually to 12.2 g/dL in a 
month time. Bilirubin decreased to 2.7 mg/dL on the third day 
after admission with direct bilirubin being 1.8 mg/dL. On admis-
sion, liver function tests were as following: SGOT 41 U/L, SGPT 
124 U/L, alkaline phosphatase 186 U/L, γGT 56 U/L. She also had 
hypokalemia and hyponatremia which were corrected by the 
administration of the appropriate fluids. The remaining bio-
chemistry findings were within the normal range. Chest X-ray 
finding was normal and abdominal ultrasound revealed mild 
hepatomegaly with normal liver echogenecity. Serological tests 
to several viruses, leptospira and ricketsia were all negative where-
as anti-Hbs were positive due to prior immunization. The 6th 
day of the disease and while the patient was still febrile, IVIG 
was administered at a dose of 2 g/kg and oral aspirin (100 mg/
kg/day) with the suspicion of KD.
  She remained afebrile the 8th day of the disease and the same 
day she also developed desquamation of fingers and toes and 
small palpable cervical lymph nodes. Echocardiograms per-
formed on the 5th, the 10th and the 15th day of the disease were 
all normal. However, one month later, the follow-up echocardio-
gram revealed dilation of the right coronary artery. Because of 
the jaundice, DNA analysis for Gilbert syndrome was performed 
which revealed that the child was heterozygous for (TA)7 promot-
er polymorphism. 
DISCUSSION
Kawasaki disease is characterized by acute systemic vasculitis 
which can affect almost any organ (3). Jaundice, due to direct 
hyperbiliburinemia, is a rare clinical feature of the disease (4). 
However, hydrops of gallbladder and acute cholestasis were de-
scribed not only as clinical features of the disease but also as atyp-
ical presenting manifestations (3). Pathophysiology of jaundice 
during KD is attributed to cholestasis, an explanation further 
supported by elevated γ-glutamyltransferase and alkaline phos-
phatase activities (4). Taking into consideration the elevated val-
ues of bilirubin, a finding rather uncommon in KD, we investi-
gated many different factors of jaundice among which Gilbert 
syndrome.
  Gilbert syndrome was first described in 1901 by Gilbert and 
Lereboulle (6). In patients with Gilbert syndrome, hepatic gluc-
uronidating activity is reduced to about 30% of normal (6). In-
deed, in 1995 Bosma et al. (7) showed the reduced expression of 
bilirubin UDP-glucuronosyltransferase 1, due to an abnormality 
in the promoter region of the gene for this enzyme. More specif-
ically, individuals with Gilbert’s syndrome were homozygous 
for two extra bases (TA) in the TATAA element of the 5 promoter 
region of the gene (7). Gilbert syndrome is common in Cauca-
sians (11%-16%) (7). It is characterized by elevated levels of un-
conjugated bilirubin and 30% elevation of bilirubin monogluc-
uronide excreted in the bile, which is less water soluble than the 
normal diglucuronide (6). Therefore, Gilbert syndrome may con-
tribute to the cholestasis induced by KD. Furthermore, one third 
of individuals with Gilbert syndrome have minor abnormalities 
in plasma clearance of bromsulfophthalein and indocyanine 
green, dyes which were considered as indicators for hepatic clear-
ance (8). These abnormalities imply that a defect in hepatic up-
take, intracellular transport or excretion of bilirubin may also 
exist. 
  Gilbert syndrome plays a role in the pathophysiology of jaun-
dice coexisting with other inducing agents such as drugs, breast 
feeding, pyelonepthiris or coinhereted disorders mainly G-6PD 
deficiency, β-thalassemia and hereditary spherocytosis (6). The 
contribution of Gilbert’s syndrome to gallbladder stone forma-
tion even in patients without hemolytic conditions is also known 
(9). More recently, an association of Gilbert syndrome with EBV 
induced cholestasis which was also reported in children with 
acute acalculous cholecystitis due to EBV infection (10). It is there-
fore evident that although Gilbert syndrome is an innocent con-
dition, it can exaggerate the clinical manifestations of indirect Karpathios T, et al.  •  Kawasaki and Gilbert Syndrome
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hyperbilirubinemia as well as cholestasis of other clinical disor-
ders. 
  In conclusion, Gilbert syndrome contributed to some extent 
to the hyperbilirubinemia of KD in our patients. Gilbert syn-
drome should therefore be considered in the etiology of jaun-
dice in children with KD. It may also be considered as a risk fac-
tor for the KD severity as elevated bilirubin is a predictive factor 
for coronary artery abnormalities. 
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